September 2, 2026
Strong growth, real margins. But KKR is asking you to absorb six years of leverage.
Former Intelligence Analyst: “Three Companies Positioned for Elon’s Next Capital Deployment”
The analyst who identified the SpaceX timeline ahead of its public milestone says Musk’s $2.1 trillion portfolio is realigning toward three publicly traded companies.
Hey there, bargain hunter. KKR just handed you a beauty brand IPO with a six-year private equity debt load baked in, filed on the last day of August straight into a market where Fed Chair Kevin Warsh’s Jackson Hole speech pushed September rate hike odds to about 57.5% on CME’s FedWatch. Welcome to the consumer listing window. Watch your wallet.
Scoreboard
The Wella Company filed its S-1 on August 31, 2026, to list on the NYSE under ticker WELA. The underwriting syndicate is led by Goldman Sachs, BofA Securities, and J.P. Morgan, and terms have not been set yet, so the price range is the next thing to watch. No share price or valuation range has been disclosed. The clock is running.
What the Business Actually Is
Wella owns brands including Wella Professionals, OPI, Briogeo, ghd, and Clairol, and employs more than 6,000 people globally. The firm operates across more than 100 countries, with primary offices in Geneva, New York City, London, and Calabasas, and a large R&D facility in Darmstadt, Germany. The revenue split is shifting: consumer net invoiced sales climbed from roughly 45% of total net invoiced sales in fiscal 2023 to approximately 52% in fiscal 2026, meaning retail is now the bigger engine.
The Numbers
- Net revenues: $2.9 billion in fiscal 2026, up from $2.7 billion in fiscal 2025 and $2.6 billion in fiscal 2024.
- Gross margin: 68.4% in fiscal 2026, improved from 66.9% two years prior.
- Adjusted EBITDA: $522.2 million in fiscal 2026, up from $415.3 million in fiscal 2024.
- Net income: $62.3 million in fiscal 2026, versus a loss of $8.7 million in fiscal 2025 and a loss of $115.2 million in fiscal 2024.
- Free cash flow: $159 million in fiscal 2026.
- Debt outstanding: approximately $2.292 billion under the Senior Facilities Agreement as of June 30, 2026.
The growth story is real. Adjusted EBITDA grew from $415 million in fiscal 2024 to $522 million in fiscal 2026, a CAGR of 12%, with margin expanding from 16% to 18%. But $2.3 billion in gross debt on $159 million of free cash flow is the number that decides whether WELA is cheap or a trap.
The AI Boom’s Structural Bottleneck: One Company Positioned at the Center
A under-covered company is building what analysts describe as a dominant infrastructure position in the AI supply chain — the kind of structural choke-point that tends to command durable pricing power.
Whitney Tilson — whom CNBC has called “The Prophet” — identifies it as the sector’s most defensible tollbooth asset. One institutional manager has allocated more than half of a $9 billion fund to the position.
It is currently trading at a valuation discount relative to its historical range — the same type of entry point that has previously preceded a re-rating of this magnitude within a 12-month window.
Is It Cheap?
KKR initially acquired a 60% stake in Wella from Coty in 2020, valuing the business at $4.3 billion, including debt. KKR has since increased its ownership, buying Coty’s remaining 25.8% stake in December 2025 for $750 million. Early reports have suggested the IPO could value Wella meaningfully above $4.3 billion. At $522 million in adjusted EBITDA, a 10x multiple implies an enterprise value near $5.2 billion, and the equity value you get after subtracting $2.3 billion of debt narrows fast.
The relevant peer universe: Coty trades at roughly 5.9x EV/EBITDA, the low end of the beauty sector. Church & Dwight commands roughly 17.5x and Procter & Gamble roughly 15.4x, rewarded for scale, pricing power, and defensive cash generation. Wella is neither a staples giant nor a distressed name, which puts the fair range somewhere between those extremes. Where KKR prices it relative to that band is everything.
The Rate Hike Wrinkle
After Fed Chair Kevin Warsh’s speech in Jackson Hole, Wyoming, CME FedWatch showed the market leaning toward a September 2026 hike, around the high-50% range at the end of August. That matters for WELA because a leveraged consumer name with about $2.3 billion of debt is not what you want to own on the day borrowing costs move higher.
The fourth signal just fired
Three chokepoint calls. Sector re-ratings of +568%, +1,754%, and +724% across three different decades. Three different industries. One pattern. That same pattern has now appeared inside the S&P 500.
Bull / Base / Bear
Bull: KKR prices WELA at 9-10x EBITDA, implying equity in the $3-3.5 billion range. Revenue grows at its recent 5% constant-currency pace, margins tick above 18%, and free cash flow compounds toward $250 million as debt is paid down.
Base: The IPO prices toward the high end, debt servicing consumes most free cash flow for two or three years, and shares trade sideways while the company delivers steady but unspectacular results.
Bear: The Fed hikes in September, rates stay higher, consumer discretionary spending softens in Europe and the Americas, and Wella’s leveraged balance sheet limits the company’s ability to invest behind brands. The stock resets toward a Coty-like multiple. That math is ugly.
They’re Paying the Toll
Palantir. Super Micro. Apple. Big names – but Dylan Jovine says they’re on the wrong side of the AI boom. They depend on the power, infrastructure and materials someone else provides. They pay the toll. One overlooked company collects it. And Dylan believes that’s where investors should be looking now.
Action Plan
Do not chase on day one. With no price range disclosed and a Fed meeting less than three weeks away, you are flying blind on valuation and into a headwind. Watch the preliminary prospectus amendment for the range. If WELA prices below 9x trailing EBITDA, the entry becomes interesting. If it prices above 12x, the debt load and rate risk mean you are paying for a best-case scenario with little margin for error. Put it on the watchlist. Let the bankers do their roadshow. The brands are strong enough to wait.
Cheap Investor Scorecard
- IPO price range vs. 10x EBITDA implied EV: Is equity value under $3.2 billion at offer?
- Debt paydown trajectory: Is Wella targeting sub-3x net leverage within 24 months?
- Free cash flow conversion: Does FCF clear $200 million in fiscal 2027?
- Revenue growth: Does constant-currency growth hold above 4% post-IPO?
- Fed outcome, September 16: Hike or hold changes the debt servicing calculus immediately.
- Consumer channel mix: Does the 52% consumer split keep expanding, or does salon stall?
- Coty distribution rights: Under the December 2025 deal announcement and related disclosures, Coty is entitled to 45% of IPO proceeds after KKR’s preferred return. Confirm the post-waterfall equity value before buying.
Bottom Line
Wella is a genuinely improved business: revenue up, margins expanding, first net profit in years. The brands are durable. The problem is you are being asked to pay a premium price for equity that sits behind $2.3 billion in debt, in a rate environment that could get more expensive in sixteen days. If the price range comes in below $3 billion of implied equity value, WELA earns a closer look. Above that, KKR is monetizing six years of work at your expense.
